Left-right determination factor is down-regulated in fibrotic renal tissue of human hydronephrosis

BJU International

Volumn 107, Issue 6, 2011, Pages 1002-1008

  Yao, Yi ^a   Zhang, Jie ^a,b   Ye, Da Fu ^a   Tan, Da Qing ^a   Peng, Jian Ping ^a   Xie, Mei ^a   Fang, Li ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b WUHAN UNIVERSITY   (China)

Author keywords

Human; Hydronephrosis; Left right determination factor (LEFTY); PCR microarray; Renal fibrosis

Indexed keywords

BONE MORPHOGENETIC PROTEIN; LEFT RIGHT DETERMINATION FACTOR; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DOWN REGULATION; FEMALE; GENE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; HYDRONEPHROSIS; KIDNEY CARCINOMA; KIDNEY FIBROSIS; LEFT RIGHT DETERMINATION FACTOR GENE; MALE; MOLECULAR BIOLOGY; NEPHRECTOMY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TISSUE SECTION; UPREGULATION;

ADULT; BONE MORPHOGENETIC PROTEINS; DOWN-REGULATION; FEMALE; FIBROSIS; HUMANS; HYDRONEPHROSIS; IMMUNOHISTOCHEMISTRY; KIDNEY; LEFT-RIGHT DETERMINATION FACTORS; MALE; MIDDLE AGED; NEPHRECTOMY; POLYMERASE CHAIN REACTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 79952601606     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2010.09520.x     Document Type: Article

References (28)

1. Mauviel A. Transforming growth factor-beta: a key mediator of fibrosis. Methods Mol Med 2005; 117: 69-80
2. Lan HY. Tubular epithelial-myofibroblast transdifferentiation mechanisms in proximal tubule cells. Curr Opin Nephrol Hypertens 2003; 12: 25-9 (Pubitemid 36092311)
3. Flanders KC. Smad3 as a mediator of the fibrotic response. Int J Exp Pathol 2004; 85: 47-64 (Pubitemid 38703594)
4. Razzaque MS, Taguchi T. Cellular and molecular events leading to renal tubulointerstitial fibrosis. Med Electron Microsc 2002; 35: 68-80 (Pubitemid 34947827)
5. Eitner F, Floege J. Therapeutic targets for prevention and regression of progressive fibrosing renal diseases. Curr Opin Investig Drugs 2005; 6: 255-61 (Pubitemid 40424733)
6. Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 2003; 425: 577-84 (Pubitemid 37280136)
7. Stambe C, Atkins RC, Tesch GH, Masaki T, Schreiner GF, Nikolic-Paterson DJ. The role of p38alpha mitogen-activated protein kinase activation in renal fibrosis. J Am Soc Nephrol 2004; 15: 370-9 (Pubitemid 38140777)
8. Nagatoya K, Moriyama T, Kawada N et al. Y-27632 prevents tubulointerstitial fibrosis in mouse kidneys with unilateral ureteral obstruction. Kidney Int 2002; 61: 1684-95 (Pubitemid 34437922)
9. Morrissey J, Hruska K, Guo G, Wang S, Chen Q, Klahr S. Bone morphogenetic protein-7 improves renal fibrosis and accelerates the return of renal function. J Am Soc Nephrol 2002; 13 (Suppl. 1): S14-21
10. Hruska KA, Guo G, Wozniak M et al. Osteogenic protein-1 prevents renal fibrogenesis associated with ureteral obstruction. Am J Physiol Renal Physiol 2000; 279: F130-43
11. Ghosh Choudhury G, Jin DC, Kim YS, Celeste A, Ghosh-Choudhury N, Abboud HE. Bone morphogenetic protein-2 inhibits MAPK-dependent Elk-1 transactivation and DNA synthesis induced by EGF in mesangial cells. Biochem Biophys Res Commun 1999; 258: 490-6 (Pubitemid 29287078)
12. Ghosh Choudhury G, Kim YS, Simon M et al. Bone morphogenetic protein 2 inhibits platelet-derived growth factor-induced c-fos gene transcription and DNA synthesis in mesangial cells. Involvement of mitogen-activated protein kinase. J Biol Chem 1999; 274: 10897-902
13. Miyazaki Y, Oshima K, Fogo A, Hogan BL, Ichikawa I. Bone morphogenetic protein 4 regulates the budding site and elongation of the mouse ureter. J Clin Invest 2000; 105: 863-73 (Pubitemid 30203059)
14. Yoo KH, Thornhill BA, Forbes MS, Chevalier RL. Inducible nitric oxide synthase modulates hydronephrosis following partial or complete unilateral ureteral obstruction in the neonatal mouse. Am J Physiol Renal Physiol 2010; 298: F62-71
15. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using realtime quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402-8 (Pubitemid 34164012)
16. Ito K, Chen J, El Chaar M et al. Renal damage progresses despite improvement of renal function after relief of unilateral ureteral obstruction in adult rats. Am J Physiol Renal Physiol 2004; 287: F1283-93
17. Mavrakis KJ, Andrew RL, Lee KL et al. Arkadia enhances Nodal/TGF-beta signaling by coupling phospho-Smad2/3 activity and turnover. PloS Biol 2007; 5: e67
18. Hartwell KA, Muir B, Reinhardt F, Carpenter AE, Sgroi DC, Weinberg RA. The Spemann organizer gene, Goosecoid, promotes tumor metastasis. Proc Natl Acad Sci USA 2006; 103: 18969-74 (Pubitemid 350002812)
19. Mendez-Davila C, Garcia-Moreno C, Turbi C, de la Piedra C. Effects of 17beta-estradiol, tamoxifen and raloxifene on the protein and mRNA expression of interleukin-6, transforming growth factor-beta1 and insulin-like growth factor-1 in primary human osteoblast cultures. J Endocrinol Invest 2004; 27: 904-12 (Pubitemid 40124184)
20. Andrieux J, Roche-Lestienne C, Geffroy S et al. Bone morphogenetic protein antagonist gene NOG is involved in myeloproliferative disease associated with myelofibrosis. Cancer Genet Cytogenet 2007; 178: 11-6 (Pubitemid 47419036)
21. Gamer LW, Cox K, Carlo JM, Rosen V. Overexpression of BMP3 in the developing skeleton alters endochondral bone formation resulting in spontaneous rib fractures. Dev Dyn 2009; 238: 2374-81
22. Meno C, Saijoh Y, Fujii H et al. Left-right asymmetric expression of the TGF beta-family member lefty in mouse embryos. Nature 1996; 381: 151-5 (Pubitemid 26137961)
23. Thisse C, Thisse B. Antivin, a novel and divergent member of the TGFbeta superfamily, negatively regulates mesoderm induction. Development 1999; 126: 229-40 (Pubitemid 29083961)
24. Ulloa L, Creemers JW, Roy S, Liu S, Mason J, Tabibzadeh S. Lefty proteins exhibit unique processing and activate the MAPK pathway. J Biol Chem 2001; 276: 21387-96
25. Ulloa L, Tabibzadeh S. Lefty inhibits receptor-regulated Smad phosphorylation induced by the activated transforming growth factor-beta receptor. J Biol Chem 2001; 276: 21397-404
26. Mason JM, Xu HP, Rao SK et al. Lefty contributes to the remodeling of extracellular matrix by inhibition of connective tissue growth factor and collagen mRNA expression and increased proteolytic activity in a fibrosarcoma model. J Biol Chem 2002; 277: 407-15 (Pubitemid 34952073)
27. Tabibzadeh S, Hemmati-Brivanlou A. Lefty at the crossroads of 'stemness' and differentiative events. Stem Cells 2006; 24: 1998-2006 (Pubitemid 44477124)
28. Tabibzadeh S. Homeostasis of extracellular matrix by TGF-beta and lefty. Front Biosci 2002; 7: d1231-46